These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 27916474)
1. Infusion of exogenous cholecystokinin-8, gastrin releasing peptide-29 and their combination reduce body weight in diet-induced obese male rats. Mhalhal TR; Washington MC; Newman K; Heath JC; Sayegh AI Appetite; 2017 Feb; 109():172-181. PubMed ID: 27916474 [TBL] [Abstract][Full Text] [Related]
2. Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats. Mhalhal TR; Washington MC; Newman K; Heath JC; Sayegh AI Physiol Behav; 2017 Oct; 179():191-199. PubMed ID: 28647503 [TBL] [Abstract][Full Text] [Related]
3. Combined gastrin releasing peptide-29 and glucagon like peptide-1 reduce body weight more than each individual peptide in diet-induced obese male rats. Mhalhal TR; Washington MC; Newman KD; Heath JC; Sayegh AI Neuropeptides; 2018 Feb; 67():71-78. PubMed ID: 29180139 [TBL] [Abstract][Full Text] [Related]
4. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents. Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356 [TBL] [Abstract][Full Text] [Related]
6. Roux-en-Y gastric bypass augments the feeding responses evoked by gastrin-releasing peptides. Washington MC; Mhalhal TR; Johnson-Rouse T; Berger J; Heath J; Seeley R; Sayegh AI J Surg Res; 2016 Dec; 206(2):517-524. PubMed ID: 27884350 [TBL] [Abstract][Full Text] [Related]
7. Factors influencing the release of cholecystokinin induced by gastrin-releasing peptide in man. Lundell L; Cantor P; Sjövall M; Rehfeld JF; Olbe L Scand J Gastroenterol; 1991 May; 26(5):544-50. PubMed ID: 1871546 [TBL] [Abstract][Full Text] [Related]
8. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats. Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV Digestion; 1991; 49(2):97-105. PubMed ID: 1724767 [TBL] [Abstract][Full Text] [Related]
9. Circulating levels of cholecystokinin and gastrin-releasing peptide in rainbow trout fed different diets. Jönsson E; Forsman A; Einarsdottir IE; Egnér B; Ruohonen K; Björnsson BT Gen Comp Endocrinol; 2006 Sep; 148(2):187-94. PubMed ID: 16630620 [TBL] [Abstract][Full Text] [Related]
10. The role of gastrointestinal peptides on pancreatic secretion in response to different stimulants in conscious rats. Ami M; Doi R; Inoue K; Chowdhury P; Rayford PL Int J Pancreatol; 1993 Dec; 14(3):245-52. PubMed ID: 8113626 [TBL] [Abstract][Full Text] [Related]
12. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway. Gourcerol G; Wang L; Wang YH; Million M; Taché Y Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219 [TBL] [Abstract][Full Text] [Related]
13. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat. Hajri A; Aprahamian M; Damgé C Digestion; 1989; 43(1-2):66-72. PubMed ID: 2806757 [TBL] [Abstract][Full Text] [Related]
14. The stomach and/or upper duodenum contain sites of action that control meal size and intermeal interval length by exogenous rat gastrin releasing peptide. Washington MC; Aglan AH; Sayegh AI Peptides; 2014 May; 55():41-6. PubMed ID: 24556509 [TBL] [Abstract][Full Text] [Related]
15. The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29. Washington MC; Mhalhal TR; Sayegh AI Horm Behav; 2016 Sep; 85():1-4. PubMed ID: 27381650 [TBL] [Abstract][Full Text] [Related]
16. Elucidating the roles of gut neuropeptides on channel catfish feed intake, glycemia, and hypothalamic NPY and POMC expression. Schroeter JC; Fenn CM; Small BC Comp Biochem Physiol A Mol Integr Physiol; 2015 Oct; 188():168-74. PubMed ID: 26151373 [TBL] [Abstract][Full Text] [Related]
17. Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ. Schwartz GJ; Moran TH; White WO; Ladenheim EE Am J Physiol; 1997 Jun; 272(6 Pt 2):R1726-33. PubMed ID: 9227583 [TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
19. Ileal interposition attenuates the satiety responses evoked by cholecystokinin-8 and -33. Metcalf SA; Washington MC; Brown TA; Williams CS; Strader AD; Sayegh AI Peptides; 2011 Jun; 32(6):1296-302. PubMed ID: 21557974 [TBL] [Abstract][Full Text] [Related]
20. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]